These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Silvis SE; Farahmand M; Johnson JA; Ansel HJ; Ho SB Gastrointest Endosc; 1996 Mar; 43(3):216-21. PubMed ID: 8857137 [TBL] [Abstract][Full Text] [Related]
23. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment. Xue Y; Zhou LY; Lin SR Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551 [TBL] [Abstract][Full Text] [Related]
26. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836 [TBL] [Abstract][Full Text] [Related]
27. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Fiorucci S; Santucci L; Morelli A Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873 [TBL] [Abstract][Full Text] [Related]
28. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Protheroe C; Woodruff SA; de Petris G; Mukkada V; Ochkur SI; Janarthanan S; Lewis JC; Pasha S; Lunsford T; Harris L; Sharma VK; McGarry MP; Lee NA; Furuta GT; Lee JJ Clin Gastroenterol Hepatol; 2009 Jul; 7(7):749-755.e11. PubMed ID: 19345285 [TBL] [Abstract][Full Text] [Related]
29. Effect of omeprazole on the course of associated esophagitis and laryngitis. Jaspersen D; Weber R; Hammar CH; Draf W J Gastroenterol; 1996 Dec; 31(6):765-7. PubMed ID: 9027637 [TBL] [Abstract][Full Text] [Related]
30. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Armstrong D; Paré P; Pericak D; Pyzyk M; Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354 [TBL] [Abstract][Full Text] [Related]
31. Allergic esophagitis in children: a clinicopathological entity. Walsh SV; Antonioli DA; Goldman H; Fox VL; Bousvaros A; Leichtner AM; Furuta GT Am J Surg Pathol; 1999 Apr; 23(4):390-6. PubMed ID: 10199468 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease. Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486 [TBL] [Abstract][Full Text] [Related]
34. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Steiner SJ; Gupta SK; Croffie JM; Fitzgerald JF Am J Gastroenterol; 2004 May; 99(5):801-5. PubMed ID: 15128340 [TBL] [Abstract][Full Text] [Related]
35. Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms. Poelmans J; Feenstra L; Tack J Dig Dis Sci; 2006 Feb; 51(2):282-8. PubMed ID: 16534670 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis. Pouderoux P; Kahrilas PJ Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654 [TBL] [Abstract][Full Text] [Related]
37. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709 [TBL] [Abstract][Full Text] [Related]
39. 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis. Lieberman DA Dig Dis Sci; 1988 Feb; 33(2):166-71. PubMed ID: 3338365 [TBL] [Abstract][Full Text] [Related]
40. Influence of pathophysiology, severity, and cost on the medical management of gastroesophageal reflux disease. Reynolds JC Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S5-12. PubMed ID: 8931825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]